ClosedBusiness
Emerging Technology Commercialisation Fund (ETCF) 2026
Office of the Chief Scientist and Engineer, Premier’s Department, NSW Government · Australia
Open, competitive and repayable NSW grant program for early-stage emerging technology companies to progress eligible innovations from TRL 3–7 toward commercial deployment. It supports physical sciences devices/systems and biological/life sciences innovations, with projects expected to strengthen commercial viability, investment readiness and long-term economic benefits for New South Wales.
Funding
$500K – $2M
Closed
29 Apr 2026
Duration
up to 2 years
Location
New South Wales
Who Can Apply
Best fit for New South Wales-headquartered for-profit deep-tech companies with sub-$2.5 million revenue, strong New South Wales employee presence, control of commercialisation IP, and an eligible physical sciences or biological sciences project already at TRL 3–7. Poor fit for digital-only software, AI platforms, subsidiaries, public companies, or businesses outside New South Wales.
- Applicant must be a company incorporated under the Corporations Act 2001 (Cth), or an Aboriginal and/or Torres Strait Islander Corporation registered under the Corporations (Aboriginal and /or Torres Strait Islander) Act 2006 (Cth).
- Applicant must be for-profit.
- Applicant must not be listed on a public stock exchange.
- Applicant must hold an active Australian Business Number.
- Applicant must be headquartered in New South Wales.
- As at 1 January 2026, more than 65% of Full Time Equivalent employees must be employed in New South Wales.
- Applicant revenue must be less than $2.5 million in FY2024/25, excluding grant funding.
- Applicant must not be a subsidiary of another company.
- Applicant must own the intellectual property or hold an exclusive licence to commercialise it in Australia and globally.
- Project must be at TRL 3–7 at application time.
- Project must progress an existing physical prototype of a device, technology or product, or a proof-of-concept of a biological or life sciences innovation.
- Project must be completed within 2 years unless exceptional circumstances apply.
- Project activities must not already have received grant funding.
- Project must not be eligible for the Medical Devices Fund funded by NSW Health.
- Digital-only applications such as software applications, data tools and AI platforms are not eligible.
What's Funded
prototyping,product development,piloting studies,manufacturing,scaling,market research,testing,trials,regulatory approvals,certifications,commercialisation strategies,commercial feasibility studies,project consumables,specialist equipment,infrastructure,intellectual property protectionExpected Outcomes
progression along TRL scale,commercial deployment readiness,improved investment readiness,early revenue potential,private investment attraction,job creation,NSW capability growthFree Eligibility Check
Answer a few quick questions to find out if you qualify for this grant. Takes about 2 minutes.
Check EligibilityKey Information
Applicant Types
startupcompanyaboriginal_and/or_torres_strait_islander_corporation
Stage
early_stagepre_scaleupcommercialisation
Funding Purposes
commercialisationprototype_progressionproduct_developmentmanufacturing_scaleupmarket_validationregulatory_readinessinvestment_readiness
Keywords
NSWEmerging Technology Commercialisation FundETCFdeep techcommercialisationTRL 3TRL 4TRL 5
Frequently Asked Questions
1
What is the Emerging Technology Commercialisation Fund (ETCF) 2026?
The Emerging Technology Commercialisation Fund (ETCF) 2026 is a business grant offered by Office of the Chief Scientist and Engineer, Premier’s Department, NSW Government in Australia, providing $500K – $2M in funding. Open, competitive and repayable NSW grant program for early-stage emerging technology companies to progress eligible innovations from TRL 3–7 toward commercial deployment. It supports physical sciences devices/systems and biological/life sciences innovations, with projects expected to strengthen commercial viability, investment readiness and long-term economic benefits for New South Wales.
2
How much funding does the Emerging Technology Commercialisation Fund (ETCF) 2026 provide?
The Emerging Technology Commercialisation Fund (ETCF) 2026 provides $500K – $2M in funding. The typical project duration is up to 2 years.
3
Who is eligible for the Emerging Technology Commercialisation Fund (ETCF) 2026?
Best fit for New South Wales-headquartered for-profit deep-tech companies with sub-$2.5 million revenue, strong New South Wales employee presence, control of commercialisation IP, and an eligible physical sciences or biological sciences project already at TRL 3–7. Poor fit for digital-only software, AI platforms, subsidiaries, public companies, or businesses outside New South Wales.
4
When does the Emerging Technology Commercialisation Fund (ETCF) 2026 close?
Applications closed on 29 Apr 2026.
5
What activities are funded?
prototyping,product development,piloting studies,manufacturing,scaling,market research,testing,trials,regulatory approvals,certifications,commercialisation strategies,commercial feasibility studies,project consumables,specialist equipment,infrastructure,intellectual property protection
6
How do I apply for the Emerging Technology Commercialisation Fund (ETCF) 2026?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.